RecallRadar

FDA Device recall Z-1078-2026

MOSAIQ Oncology Information System with Particle Therapy License (License Kit 45700000000IQRO)

On 2026-01-21 the FDA classified a Class II recall of MOSAIQ Oncology Information System with Particle Therapy License (License Kit 45700000000IQRO) by Elekta, citing using oncology information system that manages workflow may result in overtreatment if:Plan delivered with Particle Therapy IHE-RO TDW-II interface,With one field per fraction or….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1078-2026
ClassificationClass II
Statusongoing
Initiated2025-12-10
Published2026-01-21
Last updated2026-09-13 11:58 UTC
CompanyElekta
DistributionUS

Product

MOSAIQ Oncology Information System with Particle Therapy License (License Kit 45700000000IQRO)

Reason

Using oncology information system that manages workflow may result in overtreatment if:Plan delivered with Particle Therapy IHE-RO TDW-II interface,With one field per fraction or last field partial treatment,Partial treatment occurs followed by treatment field interruptions with manually recorded partial treatment,Then treatment unit doesn't check meterset value so partial treatment delivered twice

Identifiers

code_info
MOSAIQ v 3.10.200, and 3.1.1.0 up to and including v 3.2.3.1 with Particle Base. Software Versions: 3.10.200, 3.1.1.0,…MOSAIQ v 3.10.200, and 3.1.1.0 up to and including v 3.2.3.1 with Particle Base. Software Versions: 3.10.200, 3.1.1.0, 3.1.2.0, 3.1.3.0, 3.1.3.1, 3.1.3.2, 3.1.3.3, 3.1.3.4, 3.2.0.0, 3.2.1.0, 3.2.1.1, 3.2.1.2, 3.2.1.3, 3.2.1.4, 3.2.2.0, 3.2.2.1, 3.2.3.0, 3.2.3.1 UDI-DI: 07340201500026, 07340201500071

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:58 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1078-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.